TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT05988216 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05928416 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT05461885 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06339281 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06352502 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06352502 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04931732 — Predictive Biomarker (PRD): TERT mRNA
Genes: TERT; EST2; TCS1; TRT
Study NCT04931732 — Predictive Biomarker (PRD): ATRX mRNA
Genes: ATRX; RAD54L; XH2
Study NCT05486182 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study NCT05486182 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06444789 — Predictive Biomarker (PRD): REM1 mRNA
Genes: REM1; GES; REM
Study NCT04943016 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05066841 — Safety Biomarker (SAF): Eosinophil cationic protein
Genes: RNASE3; ECP; RNS3
Study NCT06526000 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT00000662 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06431230 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06086678 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT06086678 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05246384 — Predictive Biomarker (PRD): DHODH mRNA
Genes: DHODH
Study NCT06071481 — Surrogate Endpoint (SUR): Serum calcium
Study NCT06207734 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT06207734 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06207734 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06481566 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06432010 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04779983 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06583421 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00863538 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT06532695 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT05985928 — Predictive Biomarker (PRD): TAS1R3 mRNA
Genes: TAS1R3; T1R3; TR3
Study NCT04812236 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05247476 — Predictive Biomarker (PRD): DIO2 mRNA
Genes: DIO2; ITDI2; TXDI2
Study NCT04668703 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05430750 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04933799 — Safety Biomarker (SAF): Interleukin 1
Study NCT05590702 — Predictive Biomarker (PRD): CD5 mRNA
Genes: CD5; LEU1
Study NCT05814562 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06424301 — Predictive Biomarker (PRD): SMC1A mRNA
Genes: SMC1A; DXS423E; KIAA0178; SB1.8; SMC1; SMC1L1
Study NCT05622591 — Predictive Biomarker (PRD): CBFA2T3 mRNA
Genes: CBFA2T3; MTG16; MTGR2; ZMYND4
Study NCT05622591 — Predictive Biomarker (PRD): GLIS2 mRNA
Genes: GLIS2; NKL
Study NCT05622591 — Predictive Biomarker (PRD): Folate receptor alpha
Genes: FOLR1; FOLR
Study NCT06363097 — Safety Biomarker (SAF): Uromodulin
Genes: UMOD
Study NCT05579665 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT05579665 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06548451 — Predictive Biomarker (PRD): SPN mRNA
Genes: SPN; CD43
Study NCT05131841 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04795583 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05237024 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06426732 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05997459 — Predictive Biomarker (PRD): FGFR1 mRNA
Genes: FGFR1; BFGFR; CEK; FGFBR; FLG; FLT2; HBGFR
Study NCT05997459 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study NCT05364645 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study NCT04849260 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT05435573 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05261594 — Predictive Biomarker (PRD): ADORA2A mRNA
Genes: ADORA2A; ADORA2
Study NCT06097546 — Predictive Biomarker (PRD): RAI14 mRNA
Genes: RAI14; KIAA1334; NORPEG
Study NCT06097546 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT05067010 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT06270381 — Predictive Biomarker (PRD): PGD mRNA
Genes: PGD; PGDH
Study NCT05157737 — Predictive Biomarker (PRD): KCNQ2 mRNA
Genes: KCNQ2
Study NCT05375838 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06221748 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05578378 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT05675592 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT06378593 — Predictive Biomarker (PRD): FGFR2 mRNA
Genes: FGFR2; BEK; KGFR; KSAM
Study NCT04420260 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT06084585 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT03938701 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06482801 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT06482801 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT06482801 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT05934331 — Predictive Biomarker (PRD): CLDN18 mRNA
Genes: CLDN18; UNQ778/PRO1572
Study NCT05231694 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT06530719 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04976309 — Predictive Biomarker (PRD): VIP mRNA
Genes: VIP
Study NCT06500260 — Predictive Biomarker (PRD): CNKSR2 mRNA
Genes: CNKSR2; CNK2; KIAA0902; KSR2
Study NCT05333068 — Predictive Biomarker (PRD): MVD mRNA
Genes: MVD; MPD
Study NCT06105476 — Predictive Biomarker (PRD): FGF21 mRNA
Genes: FGF21; UNQ3115/PRO10196
Study NCT06573333 — Surrogate Endpoint (SUR): Serum calcium
Study NCT05544968 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT05256745 — Predictive Biomarker (PRD): AGER mRNA
Genes: AGER; RAGE
Study NCT05057884 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06369363 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06369363 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06369363 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06369363 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT05535166 — Predictive Biomarker (PRD): SHH mRNA
Genes: SHH
Study NCT05648565 — Predictive Biomarker (PRD): PNN mRNA
Genes: PNN; DRS; MEMA
Study NCT04913493 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT05117827 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT05759949 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT05785936 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-B
Genes: AS
Study NCT05132777 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06551116 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05239598 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05801978 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05638243 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT05078723 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT05770167 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05310825 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04700228 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06079151 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT05184933 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05821725 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05643742 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05951829 — Predictive Biomarker (PRD): GAST mRNA
Genes: GAST; GAS
Study NCT05673694 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT05673694 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05356559 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05356559 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05891093 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05891093 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04880395 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06147206 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06147206 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT06245538 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06245538 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06245538 — Safety Biomarker (SAF): BDNF
Study NCT06245538 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05002322 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05376878 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05941832 — Predictive Biomarker (PRD): SMPD1 mRNA
Genes: SMPD1; ASM
Study NCT06574776 — Predictive Biomarker (PRD): CPE mRNA
Genes: CPE
Study NCT05849740 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT05271318 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05271318 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT05112835 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05827302 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06287307 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05798507 — Predictive Biomarker (PRD): PTK2 mRNA
Genes: PTK2; FAK; FAK1
Study NCT04737785 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT05748925 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05124327 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04377152 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05188495 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05188495 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05254288 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT05536973 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05536973 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT05379829 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06459856 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05001997 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06100874 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04767841 — Pharmacodynamic Biomarker (PDY): 5'-AMP-activated protein kinase subunit beta-1
Genes: PRKAB1; AMPK
Study NCT04767841 — Predictive Biomarker (PRD): SIRT3 mRNA
Genes: SIRT3; SIR2L3
Study NCT04767841 — Predictive Biomarker (PRD): PINK1 mRNA
Genes: PINK1
Study NCT04128072 — Predictive Biomarker (PRD): CCR4 mRNA
Genes: CCR4; CMKBR4
Study NCT01203163 — Predictive Biomarker (PRD): HGD mRNA
Genes: HGD; HGO
Study NCT05282537 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05077254 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06204822 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04963946 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT04963946 — Predictive Biomarker (PRD): PLCG2 mRNA
Genes: PLCG2
Study NCT06117644 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05584722 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT05382819 — Predictive Biomarker (PRD): DYRK1A mRNA
Genes: DYRK1A; DYRK; MNB; MNBH
Study NCT04868201 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT04960332 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study NCT06180005 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06180005 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT06180005 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study NCT06180005 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT06180005 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT06180005 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT05274243 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05887206 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT05887206 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT05754736 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05754736 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Plasma DNA
Study NCT05813054 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study NCT04828928 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT06084065 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05194475 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05506306 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05506306 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05549999 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT05855200 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT05063097 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study NCT05055479 — Predictive Biomarker (PRD): VIM mRNA
Genes: VIM
Study NCT05744583 — Predictive Biomarker (PRD): ABO mRNA
Genes: ABO
Study NCT05155436 — Surrogate Endpoint (SUR): Serum potassium
Study NCT06663839 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT06612086 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05564546 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT06318299 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT06318299 — Safety Biomarker (SAF): BDNF
Study NCT05978050 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05441098 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT06532721 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study NCT05476029 — Monitoring Biomarker (MOI): Heme oxygenase 1
Genes: HMOX1; HO; HO1
Study NCT05752045 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT04739579 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04502394 — Predictive Biomarker (PRD): MDM2 mRNA
Genes: MDM2
Study NCT04205136 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06337708 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06448039 — Predictive Biomarker (PRD): FGF2 mRNA
Genes: FGF2; FGFB
Study NCT06256419 — Predictive Biomarker (PRD): NOS1AP mRNA
Genes: NOS1AP; CAPON; KIAA0464
Study NCT06256419 — Predictive Biomarker (PRD): KCNQ1 mRNA
Genes: KCNQ1; KCNA8; KCNA9; KVLQT1
Study NCT06256419 — Predictive Biomarker (PRD): TCF7L2 mRNA
Genes: TCF7L2; TCF4
Study NCT06583785 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06583785 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05745740 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06348264 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT06576544 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05687019 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05251038 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT00001030 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06271785 — Pharmacodynamic Biomarker (PDY): High-frequency oscillations
Study NCT05926297 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05223686 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05223686 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT06339749 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Placenta growth factor
Genes: PGF; PGFL; PLGF
Study NCT06339749 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06574919 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT06574919 — Predictive Biomarker (PRD): GNE mRNA
Genes: GNE; GLCNE
Study NCT06574919 — Predictive Biomarker (PRD): TTN mRNA
Genes: TTN
Study NCT06574919 — Predictive Biomarker (PRD): RYR1 mRNA
Genes: RYR1; RYDR
Study NCT06574919 — Predictive Biomarker (PRD): NEB mRNA
Genes: NEB
Study NCT06574919 — Predictive Biomarker (PRD): TK2 mRNA
Genes: TK2
Study NCT06574919 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study NCT04751955 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study NCT05975541 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04752332 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04752332 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04752332 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06463106 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT05349422 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05979792 — Predictive Biomarker (PRD): CD7 mRNA
Genes: CD7
Study NCT05979792 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT04243122 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT06379282 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05750524 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04629027 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04629027 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT05052294 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT05105867 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04906733 — Predictive Biomarker (PRD): RAF1 mRNA
Genes: RAF1; RAF
Study NCT05319418 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05900973 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06515262 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT06515262 — Predictive Biomarker (PRD): GPRC5D mRNA
Genes: GPRC5D
Study NCT05479461 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04883814 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study NCT05099718 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05776394 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05797597 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT05797597 — Predictive Biomarker (PRD): TMPRSS2 mRNA
Genes: TMPRSS2; PRSS10
Study NCT05797597 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT05797597 — Predictive Biomarker (PRD): IFNL1 mRNA
Genes: IFNL1; IL29; ZCYTO21
Study NCT05797597 — Predictive Biomarker (PRD): IFNL2 mRNA
Genes: IFNL2; IL28A; ZCYTO20
Study NCT05797597 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT05663164 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT05709574 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study NCT04674254 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04674254 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT06023745 — Predictive Biomarker (PRD): FNDC5 mRNA
Genes: FNDC5; FRCP2
Study NCT06364176 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT06364176 — Predictive Biomarker (PRD): CFTR
Genes: MRP7; ABC35; TNR-CFTR; dJ760C5.1; CFTR/MRP
Study NCT05708300 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study NCT00000850 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00000850 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04986345 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05040217 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT05040217 — Safety Biomarker (SAF): BDNF
Study NCT05884034 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT05893940 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04859374 — Predictive Biomarker (PRD): CPM mRNA
Genes: CPM
Study NCT06186986 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT05648019 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04798586 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT06577688 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05416411 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0